Stew B T, Fishpool S J C, Owens D, Quine S
Department of ENT Surgery, Singleton Hospital, Swansea, UK.
B-ENT. 2013;9(2):161-3.
Muckle-Wells syndrome (MWS) is a rare autosomal dominant condition with variable expression. It is a subset of auto-inflammatory diseases characterised by recurrent inflammatory crises and is associated with chronic recurrent urticaria, sensorineural deafness, periodic arthritis and secondary amyloidosis. The diagnosis of MWS is a clinical one with sufferers classically presenting in childhood with a moderate fever and non-pruiginous urticaria. We describe a case of a six-year-old girl who was successfully diagnosed and treated with Anakinra. Muckle and Wells originally described this syndrome in 1962; however, only recently was it discovered to be genetically linked to chromosome 1q44 and subsequently to missense mutations in the CIAS1/NALP3/PYPAF1 gene. Since then, treatment has evolved and it remains one of few treatable causes of congenital profound sensorineural hearing loss.
穆克-韦尔斯综合征(MWS)是一种罕见的常染色体显性遗传病,表现多样。它是自身炎症性疾病的一个子集,其特征为反复出现炎症危象,并与慢性复发性荨麻疹、感音神经性耳聋、周期性关节炎和继发性淀粉样变性有关。MWS的诊断基于临床,患者通常在儿童期出现中度发热和非瘙痒性荨麻疹。我们描述了一例成功诊断并使用阿那白滞素治疗的6岁女孩病例。穆克和韦尔斯于1962年首次描述了这种综合征;然而,直到最近才发现它与1号染色体q44区域存在基因关联,随后又发现与CIAS1/NALP3/PYPAF1基因的错义突变有关。从那时起,治疗方法不断发展,它仍然是先天性重度感音神经性听力损失少数可治疗的病因之一。